Trials / Not Yet Recruiting
Not Yet RecruitingNCT07413263
Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients
Impact of Tyrosine Kinase Inhibitors on Glucose and Lipid Metabolism in Chronic Myeloid Leukemia
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism
Detailed description
to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism and how danger they drugs be
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tyrosine kinase Inhibitors (Imatinib & Nilotinib) | these drugs used in CML only |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2027-12-30
- Completion
- 2028-12-30
- First posted
- 2026-02-17
- Last updated
- 2026-02-18
Source: ClinicalTrials.gov record NCT07413263. Inclusion in this directory is not an endorsement.